交大昂立,600530,收入构成,报告日期,2018-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),510,161,350,68.5%,2.47% 其他,10919,6503,4416,40.44%,31.15% 保健品,13475,4062,9412,69.85%,66.39% 交大昂立,600530,收入构成,报告日期,2017-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),258,178,80,31.09%,0.53% 其他,10614,5711,4903,46.2%,32.4% 保健品,16123,5976,10148,62.94%,67.07% 交大昂立,600530,收入构成,报告日期,2016-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),370,86,284,76.84%,1.88% 其他,8439,4986,3453,40.92%,22.88% 保健品,16517,5164,11353,68.73%,75.23% 交大昂立,600530,收入构成,报告日期,2016-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),257,32,225,87.52%,2.73% 其他,3997,2420,1577,39.44%,19.12% 保健品,9574,3131,6443,67.3%,78.15% 交大昂立,600530,收入构成,报告日期,2015-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),234,35,199,84.92%,1.35% 其他,6379,3859,2520,39.5%,17.08% 保健品,18562,6526,12035,64.84%,81.57% 交大昂立,600530,收入构成,报告日期,2015-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,2550,1465,1085,42.55%,13.19% 其他(补充),154,3,151,97.81%,1.83% 保健品,10971,3977,6994,63.75%,84.99% 交大昂立,600530,收入构成,报告日期,2014-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,8485,5445,3040,35.83%,14.9% 保健品,24590,7789,16802,68.33%,82.34% 其他(补充),688,124,564,81.99%,2.77% 交大昂立,600530,收入构成,报告日期,2014-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),601,-- ,-- ,--,0% 其他,4607,3375,1232,26.74%,12.32% 保健品,13053,4283,8770,67.19%,87.68% 交大昂立,600530,收入构成,报告日期,2013-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),388,-- ,-- ,--,0% 其他,6666,4141,2525,37.88%,11.42% 保健品,28650,9069,19580,68.34%,88.58% 交大昂立,600530,收入构成,报告日期,2013-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),307,-- ,-- ,--,0% 其他,3966,2805,1160,29.26%,9.7% 保健品,15095,4292,10803,71.57%,90.3% 交大昂立,600530,收入构成,报告日期,2012-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),435,-- ,-- ,--,0% 其他,5903,3778,2125,36%,8.77% 保健品,31189,9087,22102,70.87%,91.23% 交大昂立,600530,收入构成,报告日期,2012-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),211,-- ,-- ,--,0% 保健品,17539,5080,12459,71.04%,92.49% 其他,2724,1712,1012,37.15%,7.51% 交大昂立,600530,收入构成,报告日期,2011-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),1347,-- ,-- ,--,0% 其他,5317,3630,1687,31.72%,7.9% 保健品,28430,8757,19673,69.2%,92.1% 交大昂立,600530,收入构成,报告日期,2011-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),155,-- ,-- ,--,0% 房产品,213,47,166,77.98%,1.35% 其他,2208,1540,668,30.24%,5.42% 保健品,15991,4501,11491,71.85%,93.23% 交大昂立,600530,收入构成,报告日期,2010-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),430,-- ,-- ,--,0% 其他,3797,2330,1467,38.63%,11.45% 房地产,486,40,445,91.7%,3.48% 保健品,14148,3255,10893,76.99%,85.07% 交大昂立,600530,收入构成,报告日期,2009-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 公司内各业务分部相互抵销,-22035,-22475,440,-2%,2.27% 其他,12873,10828,2045,15.88%,10.53% 天然元产品,15659,7946,7713,49.26%,39.71% 昂立自产产品,24685,15460,9225,37.37%,47.49% 交大昂立,600530,收入构成,报告日期,2009-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,2895,2107,788,27.23%,7.75% 房地产,78,15,63,81.27%,0.62% 保健品,12741,3414,9326,73.2%,91.63% 交大昂立,600530,收入构成,报告日期,2008-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,6145,4465,1680,27.34%,15.46% 房地产,216,-- ,-- ,--,0% 保健品,11957,2772,9186,76.82%,84.54% 交大昂立,600530,收入构成,报告日期,2007-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其它,2679,886,1793,66.93%,14.49% 植物提取,3709,3270,439,11.84%,3.55% 房地产,13578,11818,1760,12.97%,14.23% 保健品,11714,3335,8379,71.53%,67.73% 交大昂立,600530,收入构成,报告日期,2006-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 公司内各业务分部相互抵销,-22892,-22633,-259,1.13%,-1.14% 其他,10678,6851,3827,35.84%,16.86% 植物提取,9299,8210,1089,11.71%,4.8% 房地产,17005,13737,3268,19.22%,14.4% 保健品,36407,21632,14775,40.58%,65.09% 交大昂立,600530,收入构成,报告日期,2006-09-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 昂立多邦,6811,1699,5111,75.05%,100% 交大昂立,600530,收入构成,报告日期,2006-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 昂立多邦,4321,793,3527,81.64%,78.86% 昂立一号,1382,436,945,68.42%,21.14% 交大昂立,600530,收入构成,报告日期,2006-03-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 昂立多邦,2785,493,2292,82.31%,100% 交大昂立,600530,收入构成,报告日期,2005-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 抵消,-20176,-20329,153,-0.76%,0.39% 其他,9488,7753,1735,18.28%,4.42% 植物提取,6338,5326,1012,15.97%,2.58% 房地产,1723,488,1235,71.66%,3.15% 保健品,37664,2533,35131,93.27%,89.47% 交大昂立,600530,收入构成,报告日期,2005-09-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 昂立多邦,2722,595,2127,78.13%,76.14% 昂立一号,1007,341,666,66.15%,23.86% 交大昂立,600530,收入构成,报告日期,2005-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 商品房,1708,446,1262,73.88%,19.28% 昂立多邦,4673,888,3786,81.01%,57.84% 昂立一号,2006,508,1498,74.69%,22.89% 交大昂立,600530,收入构成,报告日期,2005-03-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 昂立多邦,3176,511,2665,83.9%,72.18% 昂立一号,1383,356,1027,74.28%,27.82% 交大昂立,600530,收入构成,报告日期,2004-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 内部抵消,-23507,0,-23507,100%,-42.94% 其他,13814,0,13814,100%,25.23% 植物提取,6314,0,6314,100%,11.53% 房地产业,37011,19381,17630,47.63%,32.2% 保健品,40497,0,40497,100%,73.97% 交大昂立,600530,收入构成,报告日期,2004-09-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 昂立多邦,3080,528,2552,82.85%,73.24% 昂立一号,1362,430,933,68.46%,26.76% 交大昂立,600530,收入构成,报告日期,2004-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 昂立多邦,4643,865,3778,81.37%,65.66% 昂立一号,2527,551,1976,78.21%,34.34% 交大昂立,600530,收入构成,报告日期,2003-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 昂立多邦,15678,2618,13059,83.3%,62.41% 昂立一号,10493,2625,7867,74.98%,37.59% 交大昂立,600530,收入构成,报告日期,2003-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 昂立多邦,1,0,1,84.28%,63.3% 昂立一号,0,0,0,78.46%,36.7% 交大昂立,600530,收入构成,报告日期,2002-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 昂立多邦胶囊,16688,4210,12477,74.77%,54.46% 昂立一号口服液,14755,4320,10435,70.72%,45.54% 交大昂立,600530,收入构成,报告日期,2002-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 广告服务,3069,0,3069,100%,13.93% 保健品,18956,0,18956,100%,86.07% 交大昂立,600530,收入构成,报告日期,2001-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 昂立多邦胶囊,16062,5093,10970,68.3%,46.81% 昂立一号口服液,18254,5788,12466,68.29%,53.19%